Package 51662-1469-1

Brand: ondansetron

Generic: ondansetron
NDC Package

Package Facts

Identity

Package NDC 51662-1469-1
Digits Only 5166214691
Product NDC 51662-1469
Product ID 51662-1469_2b39dbc0-2d09-0a7f-e063-6394a90add31
Description

2 mL in 1 VIAL, SINGLE-DOSE (51662-1469-1)

Marketing

Marketing Status
Marketed Since 2019-12-14
Brand ondansetron
Generic ondansetron
Sample Package No

Linked Drug Pages (1)

ONDANSETRON ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "2b39dbc0-2d09-0a7f-e063-6394a90add31", "openfda": {"unii": ["NMH84OZK2B"], "rxcui": ["1740467"], "spl_set_id": ["99ac0a5e-dd2a-4352-e053-2a95a90a68fd"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 VIAL, SINGLE-DOSE (51662-1469-1)", "package_ndc": "51662-1469-1", "marketing_start_date": "20191214"}], "brand_name": "ONDANSETRON", "product_id": "51662-1469_2b39dbc0-2d09-0a7f-e063-6394a90add31", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Serotonin 3 Receptor Antagonists [MoA]", "Serotonin-3 Receptor Antagonist [EPC]"], "product_ndc": "51662-1469", "generic_name": "ONDANSETRON", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ONDANSETRON", "active_ingredients": [{"name": "ONDANSETRON HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA077548", "marketing_category": "ANDA", "marketing_start_date": "20191214", "listing_expiration_date": "20261231"}